Dmitry Alekseevich Soldatov
Research Subjects
Dmitry Alekseevich Soldatov has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Alexander S. Fomin
1 shared publication- Alexander S. Fomin
Institute of Biochemistry and Physiology of Plants and Microorganisms, Saratov Scientific Centre of the Russian Academy of Sciences, Saratov 410049, Russia
1 shared publication Anna Dmitrievna Klyukina
Саратовский государственный университет генетики, биотехнологии и инженерии имени Н.И. Вавилова
1 shared publication- Boris Nikolayevich Khlebtsov
Federal Research Centre “Saratov Scientific Centre of the Russian Academy of Sciences
1 shared publication Daniil S. Chumakov
1 shared publication- Daniil S. Chumakov
Institute of Biochemistry and Physiology of Plants and Microorganisms, Saratov Scientific Centre of the Russian Academy of Sciences, Saratov 410049, Russia
1 shared publication
Latest Publications
- Open Access
- 31 August 2023
- Published by FSBEU HE Saratov SAU in The Agrarian Scientific Journal
- No. 8,p. 92-96
Construction and study of the properties of a veterinary medicine based on silymarin and gold nanoparticles
Research on nanomaterials is currently very promising, thanks to them we can deliver the necessary substance, bypassing the barriers of the body. Silymarin has an anti-inflammatory effect due to its antioxidant properties, which have been repeatedly confirmed by experiments. The work was carried out on the basis of the Department of "Animal Diseases and VSE" and the CCP "Molecular Biology" of the Vavilov University. The work consisted of several stages, where we synthesized the drug silymarin-gnp, obtained polyclonal antibodies for silymarin, and carried out antibody labeling. And they were engaged in the detection of silymarin in the cells of the reticuloendothelial system. Thus, the study of the created conjugate of silymarin and colloidal gold nanoparticles made it possible to determine that animals immunized with the resulting drug are able to produce antibodies to it, and the sizes of nanoparticles in it do not exceed 20-23 nm.
- 31 August 2023
- Published by FSBEU HE Saratov SAU in The Agrarian Scientific Journal
- No. 8,p. 92-96
Open AccessConstruction and study of the properties of a veterinary medicine based on silymarin and gold nanoparticles
Research on nanomaterials is currently very promising, thanks to them we can deliver the necessary substance, bypassing the barriers of the body. Silymarin has an anti-inflammatory effect due to its antioxidant properties, which have been repeatedly confirmed by experiments. The work was carried out on the basis of the Department of "Animal Diseases and VSE" and the CCP "Molecular Biology" of the Vavilov University. The work consisted of several stages, where we synthesized the drug silymarin-gnp, obtained polyclonal antibodies for silymarin, and carried out antibody labeling. And they were engaged in the detection of silymarin in the cells of the reticuloendothelial system. Thus, the study of the created conjugate of silymarin and colloidal gold nanoparticles made it possible to determine that animals immunized with the resulting drug are able to produce antibodies to it, and the sizes of nanoparticles in it do not exceed 20-23 nm.
- Open Access
- 18 November 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (22) , 14313
Immunization of Mice with Gold Nanoparticles Conjugated to Thermostable Cancer Antigens Prevents the Development of Xenografted Tumors
Gold nanoparticles as part of vaccines greatly increase antigen stability, antigen accumulation in the lymph nodes, and antigen uptake by antigen-presenting cells. The use of such particles as part of anticancer vaccines based on heat shock proteins to increase vaccine effectiveness is timely. We prepared and characterized nanoconjugates based on 15-nm gold nanoparticles and thermostable tumor antigens isolated from MH22a murine hepatoma cells. The whole-cell lysate of MH22a cells contained the main heat shock proteins. BALB/c mice were injected with the conjugates and then received transplants of MH22a cells. The highest titer was produced in mice immunized with the complex of gold nanoparticles + antigen with complete Freund’s adjuvant. The immunized mice showed no signs of tumor growth for 24 days. They also showed a decreased production of the INF-γ, IL-6, and IL-1 proinflammatory cytokines compared to the mice immunized through other schemes. This study is the first to show that it is possible in principle to use gold nanoparticles in combination with thermostable tumor antigens for antitumor vaccination. Antitumor vaccines based on thermostable tumor antigens can be largely improved by including gold nanoparticles as additional adjuvants.
- 18 November 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (22) , 14313
Open AccessImmunization of Mice with Gold Nanoparticles Conjugated to Thermostable Cancer Antigens Prevents the Development of Xenografted Tumors
Gold nanoparticles as part of vaccines greatly increase antigen stability, antigen accumulation in the lymph nodes, and antigen uptake by antigen-presenting cells. The use of such particles as part of anticancer vaccines based on heat shock proteins to increase vaccine effectiveness is timely. We prepared and characterized nanoconjugates based on 15-nm gold nanoparticles and thermostable tumor antigens isolated from MH22a murine hepatoma cells. The whole-cell lysate of MH22a cells contained the main heat shock proteins. BALB/c mice were injected with the conjugates and then received transplants of MH22a cells. The highest titer was produced in mice immunized with the complex of gold nanoparticles + antigen with complete Freund’s adjuvant. The immunized mice showed no signs of tumor growth for 24 days. They also showed a decreased production of the INF-γ, IL-6, and IL-1 proinflammatory cytokines compared to the mice immunized through other schemes. This study is the first to show that it is possible in principle to use gold nanoparticles in combination with thermostable tumor antigens for antitumor vaccination. Antitumor vaccines based on thermostable tumor antigens can be largely improved by including gold nanoparticles as additional adjuvants.
- Open Access
- 26 April 2022
- Published by Beilstein Institut in Beilstein Archives
- Vol. 2022 (1) , 28
Immunization of mice with gold nanoparticles conjugated to thermostable tumor antigens prevents tumor development during transplantation
Gold nanoparticles as part of vaccines greatly increase antigen stability, antigen accumulation in the lymph nodes, and antigen uptake by antigen-presenting cells. The use of such particles as part of anticancer vaccines based on heat shock proteins to increase vaccine effectiveness is timely. We prepared and characterized nanoconjugates based on 15-nm gold nanoparticles and thermostable tumor antigens isolated from MH22a murine hepatoma cells. BALB/c mice were injected with the conjugates and then received transplants of MH22a cells. The immunized mice showed no signs of tumor growth for 24 days. They also showed decreased production of the INF-γ, IL-6, and IL-1 proinflammatory cytokines, as compared to the mice immunized through other schemes. This study is the first to show that it is possible in principle to use gold nanoparticles in combination with thermostable tumor antigens for antitumor vaccination. Antitumor vaccines based on thermostable tumor antigens can be largely improved by including gold nanoparticles as additional adjuvants.
- 26 April 2022
- Published by Beilstein Institut in Beilstein Archives
- Vol. 2022 (1) , 28
Open AccessImmunization of mice with gold nanoparticles conjugated to thermostable tumor antigens prevents tumor development during transplantation
Gold nanoparticles as part of vaccines greatly increase antigen stability, antigen accumulation in the lymph nodes, and antigen uptake by antigen-presenting cells. The use of such particles as part of anticancer vaccines based on heat shock proteins to increase vaccine effectiveness is timely. We prepared and characterized nanoconjugates based on 15-nm gold nanoparticles and thermostable tumor antigens isolated from MH22a murine hepatoma cells. BALB/c mice were injected with the conjugates and then received transplants of MH22a cells. The immunized mice showed no signs of tumor growth for 24 days. They also showed decreased production of the INF-γ, IL-6, and IL-1 proinflammatory cytokines, as compared to the mice immunized through other schemes. This study is the first to show that it is possible in principle to use gold nanoparticles in combination with thermostable tumor antigens for antitumor vaccination. Antitumor vaccines based on thermostable tumor antigens can be largely improved by including gold nanoparticles as additional adjuvants.